By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

HemaQuest 

233 Needham Street
Suite 300
Newton  Massachusetts  02464  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
HemaQuest Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 6/10/2013 10:31:39 AM
HemaQuest Raises $13 Million in Series B Extension Financing 3/12/2012 7:21:34 AM
HemaQuest Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 9/12/2011 11:18:04 AM
HemaQuest Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 4/26/2011 8:45:39 AM
HemaQuest Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology 12/7/2010 7:33:46 AM
HemaQuest Announces John P. Longenecker, Ph.D. to Serve as President and CEO; Company Establishes Headquarters in San Diego 12/3/2010 6:49:12 AM
HemaQuest Names New CEO 11/17/2010 7:56:50 AM
HemaQuest Initiates Phase 2 Clinical Trial in EBV-Related Malignancies 8/11/2010 8:16:00 AM
HemaQuest Raises $4M More, Boosting VC Round to $16M for Sickle Cell, Blood Disorders 7/28/2010 7:18:57 AM
HemaQuest Secures $12 Million to Advance Clinical Programs 4/21/2010 6:24:45 AM
12
//-->